Entering text into the input field will update the search result below

Long and Short Ideas for February 24th with PatternDNA

Feb. 24, 2011 10:31 AM ETNTR, MOS, CF, BIDU, CRUS, ISRG, CHBT
ZignalsApps profile picture
ZignalsApps's Blog
45 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Using the free version of PatternDNA we took a look at Jim Cramer's Lightening Round picks as provided by Miriam Metzinger. Once again, Jim sticks with Potash (POT) on the bull side, in addition we have Mosaic (MOS), CF Industries (CF), Agrium (AGU), and Baidu (BIDU) - one of our CANSLIM stocks. On the bearish side we ahve Cirrus Logic (CRUS), Intuitive Surgical (ISRG) - another one of our CANSLIM stocks - and China Biotics (CHBT).

Stock No. of
Patterns
1-day
% Win
2-day
% Win
5-day
% Win
Average Return
Per Trade (> 5 day)
POT 23 65 86 78 3.4
MOS 28 68 65 51 6.9
CF 18 57 46 50 5.8
AGU 77 40 49 59 4.3
BIDU 109 74 67 69 6.1
CRUS 208 58 58 62 5.2
ISRG 222 59 58 61 4.0
CHBT 103 57 59 53 4.6

No surprise to see PatternDNA offer a high degree of bullishness going forward, although the probability of a higher gain kicks off on day 1 after the Pattern at 60% and stays around the 60% mark until day 5. This suggests a short term bounce which fails to build after the initial first day response.

The most bullish short term projections were for Potash (POT) and Baidu (BIDU), although Mosaic (MOS) offerered the highest Average Return Per Trade at 6.9%.

While the short term outlook for Potash (POT) was very positive, its Average Return per Trade basis the lowest of the eight at 3.4% (with 57% winners). Baidu (BIDU) may have the best outlook gonig forward with 64.5% winners with an Average Return per Trade of 6.1%.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You